Ypsomed Holding AG (YPHDF)
OTCMKTS · Delayed Price · Currency is USD
535.75
0.00 (0.00%)
At close: Jul 21, 2025
Ypsomed Holding AG Employees
Ypsomed Holding AG had 2,644 employees as of March 31, 2025. The number of employees increased by 348 or 15.16% compared to the previous year.
Employees
2,644
Change (1Y)
348
Growth (1Y)
15.16%
Revenue / Employee
$320,417
Profits / Employee
$37,440
Market Cap
6.59B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2,644 | 348 | 15.16% |
| Mar 31, 2024 | 2,296 | 237 | 11.51% |
| Mar 31, 2023 | 2,059 | 136 | 7.07% |
| Mar 31, 2022 | 1,923 | 186 | 10.71% |
| Mar 31, 2021 | 1,737 | 110 | 6.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Ypsomed Holding AG News
- 9 months ago - Novo Nordisk (NVO) Partners with Ypsomed for Next-Gen Obesity Drug Delivery - GuruFocus
- 9 months ago - Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens - Seeking Alpha